Blood viscosity is a determinant of vascular resistance, and it is expected to contribute to blood pressure. Arterial hypertension (HTN), in addition to other cardiovascular risk factors, contribute to cardiac morbidity. Our study aimed to establish the association between cardiovascular risk factors including HTN and whole blood viscosity in Ecuadorian patients.
Material and methods
We studied 132 patients with the diagnosis of HTN. Fifteen cardiovascular risk factors were analyzed. The association between whole blood viscosity (WBV) and the number of cardiovascular risk factors was studied. The association between blood viscosity and risk factors was analyzed.
One hundred and thirty-two patients were analyzed. Blood viscosity was associated with a number of cardiovascular risk factors. Creatinine, uric acid, total cholesterol, and low-density lipoprotein (LDL) values were significantly higher in patients with high blood viscosity.
Blood viscosity is a physiological variable associated with a number of cardiovascular risk factors in hypertensive patients. Such risk factors are related to renal function and lipid profiles. In high-altitude residents, polycythemia is common, and the consequences of high hematocrit on cardiovascular morbidity in this setting deserve special attention and warrant further research.
Whole blood behaves as a non-Newtonian fluid, whose viscosity depends on shear rate. At low shear rates, blood cells aggregate, increasing viscosity, whereas the opposite happens at a high shear rate [1-3]. Increased whole blood viscosity (WBV) is associated with higher morbidity and mortality in some settings, including cardiovascular and cerebrovascular disease . Blood viscosity is directly proportional to endothelial shear stress, which in turn is determined by vessel diameter, through the release of endothelial vasoactive factors [4-5]. Therefore, vasodilation increases shear stress and fluid viscosity without changing the flow rate . In conditions associated with elevated levels of WBV, endothelial shear stress is further altered .
In the human microvasculature, shear stress induces nitric oxide-mediated vasodilation. This phenomenon is blunted in hypertensive patients. By contrast, small vessels of patients with hypercholesterolemia exhibit normal vasodilation induced by shear stress despite diminished nitric oxide activity . Atheroma formation involves the buildup by the accumulation of low-density lipoprotein in relation to elevated blood viscosity in areas of low flow, thus predisposing to thrombosis [8-9]. High-density lipoprotein, on the other hand, is protective against atherosclerosis by decreasing blood viscosity in areas that are prone to thrombus formation. Additionally, blood viscosity contributes to the development of HTN by increasing systemic vascular resistance . The combination of HTN and high WBV has been identified as a contributor to cardiovascular complications including left ventricular hypertrophy .
In Ecuador, the morbidity rates for HTN in 2007 and 2011 were 6.20 and 6.83, respectively . HTN by itself increases the risk of adverse cardiac events two to three times . Due to its high prevalence, it is expected that HTN will contribute to approximately 35% of the overall cardiovascular risk and atherosclerosis. Several studies reveal the association between HTN and metabolic conditions such as hypercholesterolemia, hypertriglyceridemia, low high-density lipoprotein (HDL), obesity, and diabetes mellitus . Our study was aimed at establishing the association between the cardiovascular risk factors including HTN and WBV in Ecuadorian patients.
Materials & Methods
After approval by the Ethics Committee of Pontificia Universidad Catolica del Ecuador, we studied a population of 180 patients with the diagnosis of HTN based on the criteria outlined in the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure . We retrospectively evaluated blood viscosity of patients presenting to the internal medicine outpatient clinic, with age range between 40 and 90 years and diagnosis of HTN, who had blood cell count and protein levels ordered for a clinical indication. Patients presenting with heart failure with an ejection fraction of less than 40% as well as those with a diagnosis of chronic obstructive pulmonary disease or obstructive pattern on pulmonary function tests were excluded. Demographic information included age, sex, ethnicity, family history of arterial hypertension, body mass index (BMI), and smoking history. Noninvasive blood pressure, blood cell counts, total protein levels, total cholesterol, HDL, low-density lipoprotein (LDL), and triglycerides were recorded. Creatinine clearance based on weight, age, and gender was calculated for each patient. Blood viscosity was calculated from hematocrit and total protein values using the equation: WBV = 0.12 × HCT + 0.17 (TP–2.07), where HCT denotes hematocrit (%) and TP the total serum protein level (g/L) . The formula estimates the blood viscosity at a level of shear force cut at 208 s-1.
We assigned records to one of two groups: group 1 included patients with increased WBV, and group 2 had normal WBV. We defined high WBV as being equal or higher than 19.02 centipoise. The association between WBV and the number of cardiovascular risk factors was analyzed using Student’s t-test and Chi-square test for the different types of variables. A calculated p-value less than 0.05 was considered statistically significant. We also compared the WBW net values according to the number of cardiovascular risk factors present in each patient, through the statistical contrast of Kruskall-Wallis. All statistical analyses were performed with SPSS 20.
One hundred and eighty patients met the inclusion criteria. One hundred and thirty-two patients had all the information needed for analysis. Eighty-three percent of patients were male. Table 1 shows means and standard deviations for demographic and clinical variables. Fourteen percent (n = 18) of patients were found to have elevated blood viscosity as determined by the WBV equation described in the Methods section .
We analyzed six cardiovascular risk factors (RF): age, family history, smoking, dyslipidemia, obesity, and kidney disease. We scored the average number of RF for each patient. In our sample, 5% of patients (n = 6) had only one RFs, 22% (n = 29) had two RFs, 35% (n = 46) had three RFs, 25% (n = 33) had four RFs, 13% (n = 17) had 5 RFs, and 1% (n = 1) had 6 RFs (Figure 1). Blood viscosity was associated with the number of cardiovascular RFs (p = 0.001; Table 2 and Figure 2).
The observed increases in blood viscosity in association with the number of RFs did not show any relationship of dependence. On the other hand, creatinine, uric acid, total cholesterol, and LDL levels were associated with increased viscosity, whereas creatinine clearance decreased with increased values of viscosity. The means and p values of the variables are shown in Table 3.
Age, sex, age at diagnosis, years of illness, family history, smoking status, body mass index, systolic and diastolic pressures, HDL cholesterol, triglyceride levels, and microalbuminuria did not show an association with blood viscosity values.
Our study found a correlation between WBV and the number of cardiovascular risk factors [13-15]. The study also found that creatinine, uric acid, total, and LDL cholesterol levels have a positive association with WBV values. The pathophysiology of atherosclerosis is a complex multifactorial process. Blood viscosity contributes to the development of atherosclerosis in virtue of its ability to increase blood flow-related shear stress . Laminar shear stress is known to be crucial for normal vascular functioning, by regulating vascular caliber and inhibiting endothelial cell proliferation, thrombosis, and inflammation. Thus, shear stress is atheroprotective. Our results are consistent with the effect of blood viscosity and vascular shear stress with atheroma formation . However, since we cannot establish a causal relationship between lipid profiles and blood viscosity, it is still possible that the changes in blood viscosity are the consequence rather than the cause of changes in lipid profile . At this point, we can affirm that hyperlipidemia coexists with increased blood viscosity. It is recognized that flow disturbance occurring near arterial bifurcations, branch ostia, and curvatures is associated with atheroma formation. Non-laminar flow promotes changes to endothelial gene expression, cytoskeletal arrangement, wound repair, leukocyte adhesion as well as to the vasoreactive, oxidative, and inflammatory states of the artery wall . Shear stress is critically important in the regulation of atheroprotective mechanisms of vascular beds . We believe that the effect of blood viscosity on shear stress is in part responsible for the formation of atherosclerotic plaques in areas of vascular non-laminar flow, and intervention of this variable might have a clinical impact on vascular health .
Mehmet et al. demonstrated that blood hyperviscosity is an independent risk factor for impaired coronary microvascular perfusion and angiogenesis . In the Edinburg study, the relationship between WBV and adverse cardiovascular events (ischemic heart disease and stroke) was examined in 1,592 people. A cumulative incidence was 17.1% of fatal and non-fatal events occurred after five years of follow-up. After adjustment for age and sex, blood viscosity (3.70 v 3.55 mPa.s), hematocrit (46.2 v 45.7%), hematocrit-corrected blood viscosity (3.57 v 3.48 mPa.s), plasma viscosity (1.35 v 1.33 mPa.s), and fibrinogen level (2.88 v 2.67 g/l) were significantly higher in subjects who experienced events than in subjects who did as those of conventional risk factors (smoking habit, diastolic blood pressure, and levels of LDL cholesterol). After adjustment for these conventional risk factors, the associations of blood viscosity and hematocrit remained significant for stroke, but not for total events, whereas those of plasma viscosity and fibrinogen remained significant for both total events and for stroke.
Chronic kidney disease (CKD) is a significant risk factor for the development of cardiovascular disease and a major contributor to cardiac-related mortality. On the other hand, blood viscosity has been associated with decreased renal function and increased urinary excretion of albumin in hypertensive patients without renal disease . In a study in patients with mitral annular calcification and newly diagnosed CKD, the authors found that patients with values of WBV higher than 5.2 cP had lower survival rates compared to patients with WBV values below that level . Our study showed a correlation between WBV and creatinine levels. Gordge et al. found that WBV is associated with progression of renal impairment in patients with diabetes mellitus . Although a causality relationship cannot be clearly established in the context of kidney disease, the intervention of the viscosity factor might prove useful to avoid complications related to vascular stasis such as dialysis access patency and vascular disease .
Hypertensive patients in our study exhibited a high prevalence of lipid profile abnormalities when blood pressure was poorly controlled. Gebrie et al. showed that red blood cell counts increase in parallel with the severity of HTN . Traditionally recognized cardiovascular risk factors (e.g., triglycerides, obesity, and cholesterol levels) have been found to be positively related to WBV or plasma viscosity . In our study, only LDL and total cholesterol were associated with WBV levels. This finding could be attributed to the sample size used in this study; however, our findings might be pointing to the possibility that the WBV has a more pronounced effect on total and LDL cholesterol compared to other lipids, opening the potential for intervention of blood viscosity as a strategy to affect these two types of cholesterol.
Blood viscosity is elevated in conditions of decreased alveolar pressure of oxygen, as happens in high altitude cities. This study was conducted in Quito, Ecuador (2800 m. of altitude), where the atmospheric pressure level is lower compared to sea level (526 mm Hg). Although it would be expected that high hematocrit secondary to altitude results in increased endothelial shear stress, individuals living at high altitude exhibit increases in red cell deformability and endothelial production of nitrous oxide [23-24]. Additionally, shear stress promotes synthesis of endothelial local vasodilators. This may explain the low mortality from ischemic cardiac and cerebral disease in high altitude residents .
Our study has limitations. The retrospective nature of the data collection allowed us to draw conclusions regarding the association of blood viscosity and cardiovascular risk factors; however, since causality could not be determined, hyperviscosity could be just an epiphenomenon in the complex network of pathophysiological mechanisms underlying vascular disease. The lack of association of blood viscosity with systolic and diastolic blood pressure seems to be counterintuitive and could be related to the small sample size. We recommend that future research efforts focus on the conduction of randomized trials to elucidate the effect of interventions on blood viscosity to affect individual cardiovascular risk factors.
Our results show that WBV is a physiological variable associated with a number of cardiovascular risk factors in hypertensive patients. Such risk factors are related to renal function and lipid profiles. In high-altitude residents, polycythemia is common, and the consequences of high hematocrit on cardiovascular morbidity in this setting deserve special attention and warrant further research.
- Pop GAM, Duncker DJ, Gardien M, Vranckx P, Versluis S, Hasan D, Slager CJ: The clinical significance of whole blood viscosity in (cardio)vascular medicine. Neth Heart J. 2002, 10:512-516.
- Naghedi-Baghdar H, Nazari S-M, Taghipour A, et al.: Effect of diet on blood viscosity in healthy humans: a systematic review. Electron Physician. 2018, 10:6563-6570. 10.19082/6563
- Nwose EU: Cardiovascular risk assessment and support techniques: whole blood viscosity assessment issues I: extrapolation chart and reference values. N Am J Med Sci. 2010, 2:165-169.
- Barakat AI: A model for shear stress-induced deformation of a flow sensor on the surface of vascular endothelial cells. J Theor Biol. 2001, 210:221-236. 10.1006/jtbi.2001.2290
- Windberger U, Bartholovitsch A, Plasenzotti R, Korak KJ, Heinze G: Whole blood viscosity, plasma viscosity and erythrocyte aggregation in nine mammalian species: reference values and comparison of data. Exp Physiol. 2003, 88:431-440.
- Davies PF: Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995, 75:519-60. 10.1152/physrev.1918.104.22.1689
- Paniagua OA, Bryant MB, Panza JA: Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation. 2001, 103:1752-1758. 10.1161/01.CIR.103.13.1752
- Sloop GD, Weidman JJ, St. Cyr JA: Atherothrombosis is a thrombotic, not inflammatory disease. Cureus. 2017, 9:e1909. Accessed: January 19, 2019: https://www.cureus.com/articles/9111-atherothrombosis-is-a-thrombotic-not-inflammatory-disease.
- Simone GD, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH: Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation. 1990, 81:107-117. 10.1161/01.CIR.81.1.107
- Sugimori H, Tomoda F, Koike T, et al.: Increased blood viscosity is associated with reduced renal function and elevated urinary albumin excretion in essential hypertensives without chronic kidney disease. Hypertens Res. 2013, 36:247-251. 10.1038/hr.2012.172
- INEC. Base de datos de nacimientos y defunciones. Ecuador en Cifras, Ecuador; 2012.
- Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. JAMA. 2003, 2560-2571. 10.1001/jama.289.19.2560
- Cetin MS, Ozcan Cetin EH, Balcı KG, et al.: The association between whole blood viscosity and coronary collateral circulation in patients with chronic total occlusion. Korean Circ J. 2016, 46:784-790. 10.4070/kcj.2016.46.6.784
- Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG: Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol. 1997, 96:168-173. 10.1046/J.1365-2141.1997.8532481.X
- Tamariz LJ, Young JH, Pankow JS, Yeh HC, Schmidt MI, Astor B, Brancati FL: Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol. 2008, 1153-1160. 10.1093/aje/kwn243
- Celik T, Balta S, Ozturk C, Iyisoy A: Whole blood viscosity and cardiovascular diseases: a forgotten old player of the game. Med Princ Pract. 2016, 499-500. 10.1159/000446916
- Cunningham KS, Gotlieb AI: The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest. 2005, 85:9-23. 10.1038/labinvest.3700215
- Gebrie A, Gnanasekaran N, Menon M, Sisay M, Zegeye A: Evaluation of lipid profiles and hematological parameters in hypertensive patients: laboratory-based cross-sectional study. SAGE Open Med. 2018, 6:1-11. 10.1177/2050312118756663
- Chiu JJ, Chien S: Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. 2011, 91:327-387. 10.1152/physrev.00047.2009
- Cho YI, Cho DJ, Rosenson RS: Endothelial shear stress and blood viscosity in peripheral arterial disease. Curr Atheroscler Rep. 2014, 16:404. 10.1007/s11883-014-0404-6
- Gordge MP, Patel A, Faint RW, Rylance PB, Neild GH: Blood hyperviscosity and its relationship to progressive renal failure in patients with diabetic nephropathy. Diabet Med. 1990, 7:880-886. 10.1111/j.1464-5491.1990.tb01323.x
- Dhar P, Eadon M, Hallak P, Munoz RA, Hammes M: Whole blood viscosity: effect of hemodialysis treatment and implications for access patency and vascular disease. Clinical Hemorheol Microcirc. 2012, 51:265-275. 10.3233/CH-2012-1532
- Martini J, Carpentier B, Chávez Negrete A, Cabrales P, Tsai AG, Intaglietta M: Beneficial effects due to increasing blood and plasma viscosity. Clinical Hemorheol Microcirc. 2006, 35:51-57.
- Erzurum SC, Ghosh S, Janocha AJ, et al.: Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc Natl Acad Sci U S A. 2007, 104:17593-17598. 10.1073/pnas.0707462104
- Faeh D, Gutzwiller F, Bopp M; Swiss National Cohort Study Group: Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation. 2009, 120:495-501. 10.1161/CIRCULATIONAHA.108.819250
Association between Blood Viscosity and Cardiovascular Risk Factors in Patients with Arterial Hypertension in a High Altitude Setting
Ethics Statement and Conflict of Interest Disclosures
Human subjects: Consent was obtained by all participants in this study. Pontificia Universidad Catolica del Ecuador issued approval Centro de Salud N0.4 Chimbacalle. After approval by the Ethics Committee of Pontificia Universidad Catolica del Ecuador, we retrospectively studied a population of 180 patients with diagnosis of HTN based on criteria outlined in the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. . Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Cite this article as:
Taco-Vasquez E D, Barrera F, Serrano-Duenas M, et al. (January 21, 2019) Association between Blood Viscosity and Cardiovascular Risk Factors in Patients with Arterial Hypertension in a High Altitude Setting. Cureus 11(1): e3925. doi:10.7759/cureus.3925
Received by Cureus: August 03, 2018
Peer review began: November 11, 2018
Peer review concluded: January 18, 2019
Published: January 21, 2019
© Copyright 2019
Taco-Vasquez et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.